ZBZarina Bilyalova

Zarina Bilyalova

*This is an algorithmically generated author record based on publicly available information.

Zarina Bilyalova has a total of 100 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • TRENDS IN INCIDENCE, STAGE DISTRIBUTION, AND MORTALITY OF PROSTATE CANCER IN THE AKMOLA REGION, 2005–2024

    by Z.A. Bilyalova, N.Y. Yermek, Zh.B. Telmanova, I.YU. Shishkin, G.S. Igissinova, S.S. Dyakov, D.K. Turebayev, A.M. Kazhitaev, G.Z. Khairli, N.S. Igissin

    Background. Regional analyses integrating prostate cancer incidence, stage at diagnosis, and mortality can identify epidemiological patterns that may be obscured by national estimates. Such evidence remains limited for Akmola Region. Objective. To characterize the age profile of prostate cancer and determine how incidence, diagnostic-stage composition, mortality changed in Akmola Region between 2005-2024. Materials and Methods. Twenty consecutive annual observations were assembled from Forms No. 7 and 35 of national cancer reporting system and from official estimates of the male resident population. For each calendar year, we derived population-based rates of newly diagnosed cases and prostate cancer deaths; incidence was additionally examined by age and stage at diagnosis. Log-linear Joinpoint models were fitted to the annual series, and temporal slopes were expressed as APC and, where applicable, AAPC, together with their 95% confidence intervals. Results. Registry returns contained 1,003 newly diagnosed cases and 413 deaths attributed to prostate cancer during the observation period. The standardized incidence series nearly doubled between the study endpoints, rising from 9.3 per 100,000 in 2005 to 19.2 in 2024; the model estimated an APC of 2.6% (p=0.002). Of all age strata, men aged 75-79 years had the highest mean annual incidence, at 189.5 per 100,000. For stages I-II, the incidence rate followed an upward trajectory (APC=3.3%; p=0.002), but these stages accounted for a progressively smaller share of all diagnoses, decreasing from 62.5% to 35.4%. A substantially steeper trajectory was observed for stage IV disease: its incidence rose from 1.4 to 10.6 per 100,000 (APC=9.8%; p<0.001), while its contribution to all registered cases expanded from 15.6% to 50.0%. Stage IV represented the largest diagnostic-stage category in 2022 and 2024. Although ASMR was lower at the end of follow-up than at baseline 5.6 versus 8.5 per 100,000 the fitted temporal slope did not differ statistically from zero (APC=−0.9%; p=0.616). Conclusions. Akmola Region experienced a clear rise in newly detected prostate cancer, with the steepest increase occurring in stage IV disease. Mortality showed no statistically reliable direction of change. The divergence between these indicators supports closer examination of regional diagnostic pathways, stage-recording practices, and subsequent population-based outcomes. Актуальность. Региональный анализ заболеваемости раком предстательной железы, стадийной структуры и смертности позволяет выявить эпидемиологические особенности, которые могут быть скрыты при оценке общенациональных показателей. Комплексные данные по Акмолинской области остаются ограниченными. Цель. Оценить возрастные особенности и многолетние тенденции заболеваемости, стадийной структуры при установлении диагноза и смертности от рака предстательной железы в Акмолинской области за 2005-2024 годы. Материалы и методы. Для 2005-2024 годов был сформирован региональный временной ряд, включавший 20 последовательных годовых наблюдений, полученных из сводных форм №7 и №35 национального канцер-регистра Республики Казахстан и официальной статистики мужского населения. В каждом календарном году зарегистрированное число новых случаев и смертей соотносили с соответствующей численностью мужского населения и выражали на 100 000 человек. Расчеты выполняли для всех возрастов без возрастной корректировки, для отдельных возрастных групп и с учетом различий в возрастной структуре населения. К годовым рядам применяли лог-линейные модели Joinpoint: направление и скорость изменения внутри каждого сегмента характеризовали посредством APC, а обобщенную динамику интервала с несколькими сегментами – посредством AAPC. Для обеих оценок приводили 95% доверительные интервалы. Результаты. Зарегистрировано 1 003 случая рака предстательной железы и 413 смертей от данного заболевания. Стандартизованный показатель заболеваемости увеличился с 9,3 на 100 000 мужчин в 2005 году до 19,2 в 2024 году (APC=2,6%; 95% ДИ: 1,0-4,7; p=0,002). Максимальный среднегодовой повозрастной показатель заболеваемости отмечен среди мужчин 75-79 лет – 189,5 на 100 000. Несмотря на увеличение заболеваемости опухолями I-II стадии (APC=3,3%; p=0,002), их доля снизилась с 62,5% до 35,4%. Заболеваемость опухолями IV стадии увеличилась с 1,4 до 10,6 на 100 000 мужчин (APC=9,8%; p<0,001), а их доля возросла с 15,6% до 50,0% и была наибольшей в 2022 и...

  • Open Access

    Breast Cancer in Kazakhstan, 2004–2023: Successful Mortality Reduction Driven by Organized Screening and Stage Shift

    by Nurbek Igissin, Zhansaya Telmanova, Indira Kudaibergenova, Gulnur Igissinova, Dulat Turebayev, Sergey Dyakov, Akzhunis Jexenova, Dariyana Kulmirzayeva, Rustem Moldagali, Daulet Baibosynov, et al.

    Objective: To quantify two-decade national trends in the breast cancer burden in Kazakhstan and evaluate the performance of the organized mammography screening programme—including stage distribution and regional heterogeneity after its scale-up. Methods: We conducted a retrospective, population-based evaluation using national registry and screening data. Population indicators (incidence, mortality, years of potential life lost) were analysed for 2004–2023; screening performance (coverage, abnormal rate, cancer detection rate, positive predictive value, benign biopsy rate, number needed to screen, programme contribution) was assessed for 2010–2023. Trends were modelled with Joinpoint; staging followed TNM (I–II “early”, III–IV “advanced”). Results: ASIR increased from 39.3 per 100,000 women in 2004 to 54.4 in 2023 (with a transient dip to 44.9 in 2020), whereas ASMR declined from 16.6 to 10.2 per 100,000 over the same interval; the mortality-to-incidence ratio decreased from 0.42 to 0.19. YPLL_75 fell from 175.1 per 100,000 in 2004 to a nadir of 76.0 in 2018, then measured 104.9 in 2023. The proportion diagnosed at stages I–II rose from 71.1% (2010) to 88.6% (2023), with corresponding declines in stage III (22.2% → 8.7%) and stage IV (6.8% → 5.1%). Following the expansion of eligibility to ages 40–70 (from 2018), screening throughput and coverage increased, but performance remained heterogeneous across regions, with variability in recall rates, detection yield, and downstream diagnostic pathways. Conclusion: Across 2004–2023, Kazakhstan experienced a favourable divergence between rising incidence and falling mortality, substantial reductions in premature mortality, and a marked shift toward earlier-stage diagnosis. These gains coincide with the maturation of the organised screening programme and broader system improvements. Consolidation will require targeted, region-specific quality-improvement bundles and resilience strategies to protect screening coverage and diagnostic capacity during system shocks.


  • Open Access

    RECTAL CANCER IN KAZAKHSTAN, 2005–2024: COMPONENT ANALYSIS OF INCIDENCE TRENDS IN THE CONTEXT OF SCREENING AND COVID-19

    by N.S. Igissin, Zh.B. Telmanova, N.A. Murzagulov, G.S. Igissinova, D.K. Turebaev, S.S. Dyakov, R.S. Moldagali, I.YU. Shishkin, A.R. Bilyalov, N.N. Mamatov, et al.

    Introduction. Rectal cancer constitutes a sizable share of the oncology workload. Reliable interpretation of long‑term trends requires disentangling demographic forces from genuine changes in age‑specific risk, particularly during program roll‑out and the service disruptions associated with COVID‑19. The aim of the study is to quantify the separate contributions of population size, age structure, and age‑specific risk to rectal cancer incidence in Kazakhstan, 2005–2024, partitioned into five phases: pre‑screening (2005–2010), early roll‑out (2011–2013), program stabilization (2014–2019), pandemic impact (2020–2021), and post‑pandemic recovery (2022–2024). Material and research methods. A population‑based retrospective study using the Ministry of Health Form No. 7 (ICD‑10: C19–C21). We applied a seven‑term decomposition with demographic components and risk‑related terms; here, “risk” denotes residual change in age‑specific incidence after removing demographic effects. Results. Over 2005–2024, 28,368 new cases were registered. The crude incidence rate (CR) increased from 7.80 to 9.13 per 100,000 (+1.34). Decomposition of CR yielded: ∑ΔA=+1.42, ∑ΔR=−0.05, ∑ΔRA=−0.03 (per 100,000), indicating a rise driven by population ageing with stable or slightly declining age-specific risks. By phase: 2005–2010 – declines in CR and ASR due to ΔR0); 2014–2019 – CR rises while ASR falls, increase fully demographic; 2020–2021 – compensatory increase versus 2020, yet 2021 below 2019; 2022–2024 – CR rises with a “flat” ASR, contribution almost exclusively demographic. Age profile stable: ages 50–79 ≈80.7% of registrations. Conclusions. The upward drift in crude incidence is primarily demographic, while true risk variation is phase‑bound and program‑linked. Policy should prioritize resilient early‑detection pathways, surge capacity for endoscopy, and routine component‑based surveillance focused on ages 50–79. Введение. Рак прямой кишки вносит существенный вклад в суммарную нагрузку онкологических заболеваний. Корректная интерпретация временных рядов требует раздельной оценки демографических эффектов и подлинной динамики возраст‑специфического риска, особенно при развёртывании организованного скрининга и структурных ограничениях периода COVID‑19. Цель исследования: количественно разложить вклад демографических факторов (численность населения и возрастная структура) и возраст‑специфического риска в изменение заболеваемости раком прямой кишки в Казахстане в 2005-2024 гг., с анализом пяти фаз: доскрининговый этап (2005-2010), раннее развёртывание (2011-2013), стабилизация программы (2014-2019), пандемическое воздействие (2020-2021) и постпандемическое восстановление (2022-2024). Материалы и методы. Популяционное ретроспективное исследование на основе официальной отчётной формы № 7 Минздрава РК (МКБ‑10: C19–C21). Для оценки динамики числа случаев применено компонентное разложение с выделением семи факторов. Результаты. За 2005–2024 гг. зарегистрировано 28 368 первичных случаев. Грубый показатель заболеваемости (ГП) вырос с 7,80 до 9,13 на 100 000 (+1,34). Декомпозиция ГП: суммарно ∑ΔA=+1,42, ∑ΔR=−0,05, ∑ΔRA=−0,03 (на 100 000) – прирост обусловлен старением населения при стабильных/слегка снижающихся возрастных рисках. По этапам: 2005–2010 – снижение ГП и ВСП за счёт ΔR0); 2014–2019 – рост ГП при снижении ВСП, прирост полностью демографический; 2020–2021 – компенсаторный рост относительно 2020 г., но уровень 2021 г. ниже 2019 г.; 2022–2024 – рост ГП при «плоском» ВСП, вклад почти исключительно демографический. Возрастной вклад устойчив: 50–79 лет ≈80,7% всех регистраций. Выводы. Долгосрочный рост заболеваемости определяется главным образом старением и увеличением численности населения; изменения «истинного» риска носят кратковременный характер и совпадают с программными и организационными сдвигами. Рекомендуется внедрять устойчивое компонентное наблюдение, планировать резерв мощности эндоскопии и фокусировать профилактику на когортах 50–79 лет. Кіріспе. Тік ішек қатерлі ісігі онкологиялық қызметтің елеулі бөлігін құрайды. Ұзақ мерзімді динамиканы дұрыс түсіндіру үшін демографиялық әсерлерді жас‑ерекшелік...

  • Open Access

    Regional analysis and stage-specific incidence of breast cancer in Kazakhstan: A comprehensive study

    by Nurbek Igissin, Assem Toguzbayeva, Zhansaya Telmanova, Gulnur Igissinova, Dulat Turebayev, Dariyana Kulmirzayeva, Nariman Syzdykov, Rustem Moldagali, Daulet Baibosynov, Zarina Bilyalova


  • ACUTE PANCREATITIS IN AKMOLA REGION ACCORDING TO EMERGENCY SURGERY

    by N.S. Igissin, Bishkek Asian Pacific Organization For Cancer Prevention, S.A. Ayaganov, R.S. Moldagali, D.K. Turebaev, A.M. Jexenova, S.K. Muratbekova, K.R. Rustemova, G.S. Igissinova, Z.A. Bilyalova, et al.

    Background: Acute pancreatitis is a major issue in surgical practice, with high complications and mortality rates. It severely affects patient quality of life and places a significant economic strain on healthcare systems, making its study crucial for public health. This study aims to analyze trends in acute pancreatitis incidence in the Akmola region from 2009 to 2022. Materials and methods: The study is based on a retrospective analysis of data from the Ministry of Health of the Republic of Kazakhstan according to the International Classification of Diseases-10 code: K85. Methods of health statistics and time series analysis were used to assess the dynamics of morbidity. Results: There was an increase in the total number of hospitalizations from 865 cases in 2009 to 1.061 in 2022. The percentage of surgical interventions decreased from 5.7% to 4.2%, while the share of conservative treatment increased to 95.8%. The mortality rate among operated patients was 20.4% in 2019 and increased to 33.3% in 2022. The incidence of hospitalization increased from 117.1 per 100000 population in 2009 to 144.6 per 100000 population in 2022, with a decrease in the rate of late visits from 42.6 to 36.1 per 100000 population, respectively. Conclusion: It has been established that for patients in the second group according to the Enhanced Recovery After Surgery strategy, hemodynamic support and effective pain management can contribute to early patient mobilization after surgery. Early mobilization, in turn, can expedite recovery and reduce the length of hospital stay, ultimately leading to potential cost savings. Conclusion. The study highlights the need to improve medical approaches to acute pancreatitis in the Akmola region. The results indicate the critical importance of early diagnosis and timely hospitalization to reduce complications and mortality. Additional research is needed to develop more effective clinical protocols.

  • Open Access

    Trends in Stage-Specific Kidney Cancer Incidence in Kazakhstan, 2005-2019

    by Nurbek Igissin, Sergey Dyakov, Zhansaya Telmanova, Indira Kudaibergenova, Serik Ayaganov, Dulat Turebayev, Akzhunis Jexenova, Gulnur S Igissinova, Saule Maukayeva, Vladimir Lust, et al.

    Objective: The aim is to analyze the incidence of kidney cancer over a 15-year period, considering factors such as stage, age, sex, and morphological verification in the regional context in Kazakhstan. Methods: The retrospective study was done using descriptive and analytical methods of oncoepidemiology. The extensive, crude and age-specific incidence rates are determined according to the generally accepted methodology used in sanitary statistics. The data were used to calculate the average percentage change (APС) using the Joinpoint regression analysis to determine the trend over the study period. Results: Among the meticulously documented 15,277 cases, a conspicuous male predominance was noted, comprising 53.7% of cases compared to 46.3% in females, with peak incidences observed within the 50-69 age cohorts. The average age at diagnosis exhibited a progressive rise over the study period, with discernible variations observed in age-specific incidence rates, particularly pronounced within the 60-84 age brackets. Noteworthy temporal trends indicated a consistent uptick in crude incidence rates, with distinct regional disparities manifesting higher rates in northern regions relative to their southern and western counterparts. Stratification by cancer stage unveiled a significant surge in stages I-II cases alongside a concomitant decrement in stage III incidences, complemented by reductions in stage IV occurrences and instances of unspecified disease stages. Morphological verification rates displayed regional variations, with an overarching ascending trajectory across most regions, albeit exceptions noted, notably in the Kyzylorda region. Conclusion: Our study identified a rise in kidney cancer incidence in Kazakhstan, likely reflecting global trends driven by increased risk factor exposure and incidental imaging findings. Regional disparities and varied stage distributions highlight the complexity of kidney cancer epidemiology. Despite advancements in early detection, delayed diagnosis persists, necessitating improved surveillance and diagnostic practices.


  • Open Access

    Trends of Breast Cancer in Astana (2012-2021): Component Analysis of Incidence

    by Kokshetau University named after Sh. Ualikhanov, Nurbek Igissin, Assem Toguzbayeva, Kazakh Research Institute of Oncology and Radiology, Nariman Syzdykov, Health Department of Akmola region, Dariyana Kulmirzayeva, Rustem Taszhanov, Svetlana Muratbekova, Zarina Bilyalova, et al.

    The purpose of this study: to evaluate the incidence of breast cancer (BC) in Astana using component analysis. Methods. In a retrospective study of the data of the Ministry of Health of the Republic of Kazakhstan on new cases of BC in Astana, obtained from Form No. 7, descriptive and analytical methods of epidemiology were used. Component analysis was used to analyze the dynamics of incidence based on the number of cases from 2012 to 2021. Results. During the study period (2012-2021), 2.672 new cases of BC were registered in Astana. The average age of the patients was 55.7 years. The average annual incidence of BC in Astana was 53.0±1.7 (95% CI=49.7-56.2) per 100.000 population. The general growth in incidence was +1.00/0000. The overall increase was +2.690/0000 and depended on changes in the age structure of the population (∑ΔA=+5.400/0000), the risk of getting sick (∑ΔR=−3.400/0000) and the combined effect of the age structure and the risk of getting sick (∑ΔAR=+0.680/0000). According to the calculations of the component analysis, 369 patients were expected in 2021. However, the number of patients was 322. Thus, BC is characterized by an increase in cases, mainly due to population growth (+56.8% of the total increase by +64.5%). Conclusion. Our research highlights the rise in breast cancer cases linked to demographic factors, primarily population growth. Simultaneously, there's a decrease in the disease's risk factor, possibly attributed to successful screening efforts. This underscores the significance of enhancing healthcare policies and raising public awareness of cancer prevention as key measures to alleviate the disease burden.

  • Open Access

    Epidemiological Aspects of Suicide in the East Kazakhstan Region

    by Gulmira Kozhakhmetova, Zaituna Khamidullina, Zhanerke Azhetova, Serikbay Orozbaev, Zarina Bilyalova, Zhansaya Telmanova, Nurbek Igissin

    Objective: To study the trends of mortality from intentional self-harm in the East Kazakhstan region.Methods. The main sources of information were the materials of the state registration of the deceased as a whole from intentional self–harm (ICD 10 - X60-84) for 2004-2013. Materials related to the East Kazakhstan region were analyzed. A retrospective study using descriptive and analytical methods of modern epidemiology was used as the main method in the study of mortality from intentional self-harm.Results. In 2004-2013, 38,276 cases of intentional injuries were registered in Kazakhstan, of which only 5998 (15.7%) suicides occurred in the East Kazakhstan region. The average age of those who died from suicide was 40.4±0.5 years. The average annual crude mortality rates from intentional self–harm among both sexes amounted to 42.2±2.40/0000 (95%CI=37.5-47.0). In dynamics, the crude mortality rate for both sexes decreased, and the average annual rate of decline was T=−5.0%. Age-sex differences in suicide mortality rates were revealed. The analysis of age-related mortality rates from intentional self-harm in both sexes in the studied region showed a unimodal increase with a peak in the age group of 30-49 years.Conclusion. The analysis of mortality from suicide showed that in the East Kazakhstan region, mortality is decreasing significantly. The data obtained make it possible to monitor trends and changes in suicide mortality. This helps to assess the effectiveness of measures to reduce the risk of suicide and adjust strategies and programs depending on changing conditions.Keywords: suicides, age and gender characteristics, epidemiology, trends, East Kazakhstan region


  • Open Access

    The impact of COVID-19 on gastric cancer incidence in Kazakhstan

    by Nurbek Igissinov, Vice President of the Eurasian Institute for Cancer Research, Rustem Taszhanov, Zhansaya Telmanova, Saken Kozhakhmetov, Kulsara Rustemova, Serikbay Orozbaev, Zhanerke Azhetova, Zarina Bilalova, Gulnur Igissinova, et al.

    Зерттеудің мақсаты: компоненттік талдау арқылы COVID 19-дың асқазан обырымен сырқаттанушылығына әсерін бағалау. Әдістері. Зерттеу материалы Қазақстан Республикасы Денсаулық сақтау министрлігінің асқазан обырына қатысты деректері (7-нысан) болды. Ретроспективті зерттеуде эпидемиологияның сипаттамалық және аналитикалық әдістері қолданылды. Компоненттік әдіс 2011 жылдан 2020 жылға дейін болған жағдайлардың санына негізделген асқазан обырымен сырқаттанушылықтың динамикасын талдау үшін қолданылды. Нәтижесі. 2011 және 2020 жылдарға талдау жасай отырып, біз бұл ауруды жұқтыру қаупінің нақты төмендегенін анықтадық. Егер пандемияға дейінгі кезеңде жағдайлардың саны 0,1%-ға артса, пандемия кезінде асқазан обырының тіркелген жағдайларының саны 6,7%-ға төмендеді. Әрі қарай, 2019 және 2020 жылдарды салыстыра отырып, біз асқазан обырымен сырқаттанушылықтың төмендегенін анықтадық. Жалпы төмендеу −1,160/0000 болды және халықтың жас құрылымының өзгеруіне (∑ΔA=+0,220/0000), ауру даму қаупіне (∑ΔR=−1,370/0000) және жас құрылымы мен ауру қаупінің жиынтық әсеріне (∑ΔAR=−0,020/0000) байланысты болды. Көріп отырғаныңыздай, төмендеу негізінен ауру даму қаупінің әсерінен болды. Компоненттік талдаудың есептеулеріне сәйкес, 2020 жылы 2757 пациент күтілді, бірақ оның орнына пациенттер саны азайып, 2497 құрады және бұл ауру даму қаупінің өзгеруіне байланысты жағдайлардың азаюымен сипатталады. Қорытынды. Қазақстанда асқазан обырымен сырқаттану төмендеу үрдісіне ие болды. Бірақ жаһандық пандемияға байланысты қауіпсіздік шараларының кесірінен 2020 жылы аурудың деңгейі одан да төмендеді. Бұған асқазан қатерлі ісігін анықтау үшін жүргізілген диагностикалық шаралардың төмендеуі әсер еткен болуы мүмкін. Осы зерттеудің нәтижелері қатерлі ісікке қарсы шараларды ұйымдастыруды жетілдіруде қолдану үшін ұсынылады. Objective: to evaluate the effect of COVID-19 on gastric cancer incidence by component analysis. Methods. The data obtained from the Ministry of Healthcare of the Republic of Kazakhstan concerning GC (Form no. 7) was retrospectively studied by descriptive and analytical epidemiology methods. The component method was used to analyze GC incidence dynamics based on the number of cases from 2011 to 2020. Results. Analyzing 2011 and 2020, we found an apparent reduction in the risk of GC. If in the period before the pandemic the number of cases increased by 0.1%, then during the pandemic the number of cases of registered gastric cancer decreased by 6.7%. The GC incidence decreased from 2019 to 2020. The incidence decreased by −1.160/0000 due to changes in the age structure of the population (∑ΔA=+0.220/0000), the risk of getting GC (∑ΔR=−1.370/0000), and combined impact of age structure and the risk of getting GC (∑ΔAR=−0.020/0000). According to the calculations of the component analysis, 2,757 patients were expected in 2020. Instead, the number of patients decreased to 2,497 due to fewer cases because of the changes in the risk of getting GC. Conclusion. In Kazakhstan, the incidence of gastric cancer tended to decrease. But due to safety measures in connection with the global pandemic in 2020, the incidence rate has decreased even more significantly. Most likely, this was influenced by a decrease in the diagnostic measures carried out to detect gastric cancer. The results of this study are recommended for use in improving the organization of anticancer activities. Цель исследования: оценить влияние COVID 19 на заболеваемость раком желудка путем компонентного анализа. Методы. В ретроспективном исследовании данных Министерства здравоохранения Республики Казахстан о новых случаях рака желудка, полученных из формы №7, использовались описательные и аналитические методы эпидемиологии. Для анализа динамики заболеваемости на основе количества случаев заболевания с 2011 по 2020 год был использован компонентный метод. Результаты. Анализируя 2011 и 2020 года, мы обнаружили явное снижение риска заражения этим заболеванием. Если в предпандемический период количество заболевших...

  • Open Access

    Evaluation of Changes in Indicators of Oncological Service for Laryngopharyngeal Cancer in Kazakhstan

    by Darkhan Ahmedin, Astana Medical University, Abay Makishev, Zhansaya Telmanova, Dinara Kassenova, Kuanish Kulayev, Zhanerke Azhetova, Serikbay Orozbaev, Gulnur Igissinova, Zarina Bilalova, et al.

    Қатерлі ісік ауруын зерттеу жөніндегі халықаралық агенттіктің болжамына сәйкес, 2040 жылы 127 мыңға жуық жаңа көмей-жұтқыншақ обыры (КЖО) болады деп болжануда және осы патологиядан 60 мыңға жуық адам қайтыс болады деп күтілуде. Зерттеудің мақсаты: 2017-2021 жылдары Қазақстанда көмей жұтқыншақ обыры кезінде онкологиялық қызметтің кейбір көрсеткіштерін бағалау. Әдістері. Зерттеу материалы Қазақстан Республикасы Денсаулық сақтау министрлігінің 2017-2021 жылдардағы КЖО (АХЖ 10 – С12, С13, С14) қатысты № 7 және 35 жылдық нысаны – сырқаттанушылық, өлім – жітім, ерте диагностика, қараусыздық, морфологиялық верификация деректері болды. Негізгі әдіс ретінде биомедициналық статистиканың сипаттамалық және аналитикалық әдістерін қолдана отырып, ретроспективті зерттеу қолданылды Нәтижесі. 2017-2021 жылдары республикада алғаш рет КЖО-ның 802 жаңа жағдайы және осы патологиядан 477 өлім жағдайы тіркелді. КЖО сырқаттанушылығыңыі орташа жылдық дөрекі көрсеткіші 0,87±0,020/0000 (95%СА=0,82-0,91) құрады және динамикада 0,90±0,070/0000 (2017 ж.) бастап 2021 жылы 0,86±0,070/0000 дейін төмендеді, айырмашылық статистикалық маңызды болған жоқ (р>0,05). Динамикада КЖО-дан болатын өлім-жітім көрсеткіштері 2021 жылы 0,48±0,050/0000 (2017 ж.) – ден 0,53±0,050/0000 -ға дейін өсу үрдісіне ие болды (р>0,05), ал КЖО -дан болатын өлім-жітімнің орташа жылдық дөрекі көрсеткіші 0,52±0,020/0000 (95%СА=0,47-0,56) құрады. Ерте диагностика көрсеткіштері (I-II сатысы бар науқастардың үлес салмағы) 2021 жылы 27,2% - дан (2017 ж.) 22,7% - ға дейін төмендеді, зерттелген жылдары III сатыдағы (60,5% - дан 62,6% - ға дейін) және IV сатыдағы (12,3% - дан 14,7% - ға дейін) науқастардың үлес салмағы ұлғайды. КЖО кезінде морфологиялық верификация көрсеткіштері айтарлықтай жоғары болды және зерттелген жылдар ішінде 96,9% - дан 98,2% - ға дейін жақсарды. Қорытынды. КЖО кезіндегі онкологиялық қызметтің көрсеткіштерін талдау нәтижесінде сырқаттанушылық көрсеткіштерінің төмендеуі, қараусыздық пен өлім-жітім көрсеткіштерінің өсуі анықталды. Денсаулық сақтау менеджерлері бұған сөзсіз назар аударуы керек және қатерлі ісікке қарсы мақсатты іс-шараларды ұйымдастыру кезінде осыны ескеруі керек. According to the forecasts of the International Agency for Research on Cancer in 2040, about 127 thousand new cases of laryngopharyngeal cancer (LFC) are predicted and it is expected that about 60 thousand people will die from this pathology. Objective: evaluation of some indicators of the oncological service for laryngopharyngeal cancer in Kazakhstan for 2017-2021. Methods. The material of the study was the data of the Ministry of Health of the Republic of Kazakhstan – annual Form No. 7 and 35 concerning LFC (ICD 10 – C12, C13, C14) for 2017-2021 – incidence, mortality, early diagnosis, neglect, morphological verification. A retrospective study using descriptive and analytical methods of biomedical statistics was used as the main method. Results. For the period 2017-2021, 802 new cases of LFC and 477 deaths from this pathology were registered for the first time in the republic. The average annual crude incidence rate of LFC was 0.87±0.020/0000 (95%CI=0.82-0.91) and decreased in dynamics from 0.90±0.070/0000 (2017) to 0.86±0.070/0000 in 2021, the difference was not statistically significant (p>0.05). In dynamics, mortality rates from LFC tended to increase from 0.48±0.050/0000 (2017) to 0.53±0.050/0000 in 2021 (p>0.05), and the average annual crude mortality rate from LFC was 0.52±0.020/0000 (95%CI=0.47-0.56). Indicators of early diagnosis (the proportion of patients with stage I-II) decreased from 27.2% (2017) to 22.7% in 2021, the proportion of patients with stage III (from 60.5% to 62.6%) and stage IV (from 12.3% to 14.7%) increased over the years studied. The indicators of morphological verification at LFC were quite high and improved from 96.9% to 98.2% over the years studied. Conclusion. As a result of the analysis of the indicators of the oncological service at LFC, a decrease in incidence rates, an increase in neglect and mortality rates have been established, which health managers should undoubtedly pay attention to and take into account when organizing targeted anti-cancer measures. По прогнозам Международного агентства по изучению рака в 2040 году прогнозируется около 127 тысяч новых...